Most cysts are benign fluid-filled sacs that never become cancerous, but a small percentage either harbor cancer already or carry the potential to develop it over time. The risk depends heavily on where the cyst is, what it looks like on imaging, and what type of tissue lines its wall. A simple fluid-filled cyst on an ovary, for instance, poses almost zero cancer risk, while a complex cyst in the pancreas with certain internal features can be a serious concern. Understanding which cysts warrant worry and which can be safely left alone is one of the more nuanced questions in medicine, and the answer varies organ by organ.
Why the Vast Majority of Cysts Are Harmless
Cysts form throughout the body for all sorts of reasons. Hormonal fluctuations produce ovarian cysts every menstrual cycle. Blocked ducts in the skin create epidermoid cysts. Kidney cysts appear so commonly with age that they are almost a normal part of getting older. In the overwhelming majority of cases, these are simple cysts: thin-walled, fluid-filled, with no solid components, no thick internal walls, and no blood flow feeding them. Simple cysts, regardless of location, are almost always benign.
The trouble starts when a cyst has features that deviate from that clean, simple profile. Thick walls, internal solid areas, irregular septations (dividers inside the cyst), or increased blood flow to the cyst wall are all features that make doctors pay closer attention. These “complex” characteristics don’t guarantee cancer, but they shift the probability enough to warrant further investigation. The specifics differ by organ, so the most useful way to think about cyst cancer risk is to look at each location separately.
Ovarian Cysts
Ovarian cysts are among the most commonly discovered cysts, especially in women of reproductive age, and the vast majority are functional cysts that form during ovulation and resolve on their own within a few menstrual cycles. These simple cysts carry essentially no cancer risk. A large study of over 72,000 women found that simple ovarian cysts were not associated with a significantly increased risk of ovarian cancer compared to women with normal-appearing ovaries. In women younger than 50, no cancers at all were identified among those with simple cysts. In women 50 and older, the three-year risk of cancer with a simple cyst was between 0 and 0.5 cases per 1,000 women.1JAMA Internal Medicine. Risk of Ovarian Cancer Based on Ultrasonography Findings in a Large Unselected Population
Complex cysts and solid masses are a different story. The same study found that women with complex cysts or solid ovarian masses had cancer risks dramatically higher than those with normal ovaries, with the three-year risk of cancer ranging from roughly 9 to 430 cases per 1,000 women depending on age and the specific ultrasound findings.1JAMA Internal Medicine. Risk of Ovarian Cancer Based on Ultrasonography Findings in a Large Unselected Population That is a wide range, and it reflects how much the details matter: a cyst with a single thin septation is far less concerning than one with thick, irregular walls and solid nodules projecting into the cavity.
For older women with an adnexal mass that stays stable on repeat imaging, the risk drops considerably. A retrospective study of over 4,000 patients aged 50 and older with stable masses under 10 cm found an overall cancer rate of about 0.27% over a median follow-up of nearly four years.2American Journal of Obstetrics & Gynecology. Ovarian cancer risk among older patients with stable adnexal masses Stability on imaging is itself reassuring. Cancers tend to grow and change; masses that sit quietly for years are far less likely to be malignant.
A separate question is whether small ovarian inclusion cysts, the tiny cysts that sometimes form on the surface of the ovary in postmenopausal women, increase cancer risk. A prospective cohort study within a large UK screening trial found no increased incidence of ovarian, endometrial, or breast cancer in women with these inclusion cysts compared to what would be expected in the general population.3PubMed. Assessing the malignant potential of ovarian inclusion cysts in postmenopausal women within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a prospective cohort study
Kidney Cysts and the Bosniak System
Kidney cysts are extremely common, and doctors have been classifying them using the Bosniak system for over 30 years to estimate cancer risk based on how a cyst looks on CT or MRI.4PubMed Central. Bosniak Classification of Cystic Renal Masses, Version 2019: An Update Proposal and Needs Assessment The system ranges from category I (a perfectly simple cyst) up through category IV (a cyst with clearly enhancing solid components that is assumed to be malignant until proven otherwise).
A systematic review and meta-analysis that pooled data across studies found that the rate of malignancy climbs steeply as you move up the Bosniak ladder. Category I cysts had a pooled malignancy rate of about 3%, category II about 6%, category IIF (a middle-ground category requiring follow-up imaging) about 7%, category III about 55%, and category IV about 91%.5PubMed Central. Malignancy rates and diagnostic performance of the Bosniak classification for the diagnosis of cystic renal lesions in computed tomography – a systematic review and meta-analysis Those numbers mean that a straightforward simple kidney cyst is overwhelmingly likely to be benign, while a cyst with thick walls, irregular septations, and areas that light up with contrast dye on imaging has a very high probability of being cancerous.
One interesting finding for Bosniak III lesions — the “indeterminate” category where surgery is often recommended — is that smaller lesions under 4 cm were actually more likely to be malignant than larger ones in one study, with about 60% of all Bosniak III lesions turning out to be cancerous on surgical pathology.6PubMed Central. The true malignancy risk of Bosniak III cystic renal lesions: Active surveillance or surgical resection? That runs counter to the intuition that bigger is scarier. With kidney cysts, it is the internal architecture, not necessarily the size, that matters most.
Inherited conditions like von Hippel-Lindau syndrome and tuberous sclerosis can also produce kidney cysts, and these carry their own set of cancer risks distinct from the typical simple or complex cysts found incidentally on scans.7Advances in Anatomic Pathology. Renal Cystic Diseases: A REVIEW If you have a family history of one of these conditions, your doctor will likely monitor kidney cysts more closely than they would for the average person.
Pancreatic Cysts
Pancreatic cysts deserve special attention because the stakes are high. Pancreatic cancer has one of the lowest survival rates of any cancer, with five-year survival in the single digits, and up to half of adults may harbor pancreatic cysts that could theoretically serve as precursors.8PubMed Central. Metabolic Characterization of Plasma and Cyst Fluid from Cystic Precursors to Pancreatic Cancer Patients Reveal Metabolic Signatures of Bacterial Infection That sounds alarming, but the overwhelming majority of these cysts are small, remain stable, and never progress to cancer. The challenge is identifying which ones will.
The type of pancreatic cyst matters enormously. Serous cystadenomas are usually benign. Mucinous cystic neoplasms, on the other hand, carry malignant potential, as do certain types of intraductal papillary mucinous neoplasms.9PubMed Central. Cystic lesions of the pancreas Then there are pseudocysts, which lack an epithelial lining altogether and are typically a consequence of pancreatitis rather than a tumor, but these need to be distinguished from cystic tumors that present in a similar way, since the majority of those tumors are malignant or carry malignant potential.10BioMed Central / Chinese Journal of Cancer. Pancreatic pseudocyst or a cystic tumor of the pancreas?
Managing pancreatic cysts is genuinely difficult. Current imaging and sampling techniques cannot perfectly characterize every cyst, so clinicians are constantly weighing the risks of unnecessary surgery against the risk of missing a cancer or precancer.11PubMed Central. Pancreatic cystic lesions: when to watch, when to operate, and when to ignore Guidelines from major gastroenterology and radiology organizations outline specific “worrisome features” and “high-risk stigmata” on imaging that should prompt referral to a surgeon or endoscopist. These include things like a solid enhancing component within the cyst, dilation of the main pancreatic duct, or a rapid change in cyst size.12Korean Journal of Radiology. The Incidental Pancreatic Cyst: When to Worry About Cancer
Breast, Skin, and Thyroid Cysts
Breast cysts are common and are typically sorted into simple and complex categories, similar to other organs. Simple breast cysts are almost always benign. Complex cystic breast lesions, however, have a measurable risk of malignancy that depends on their internal features. One study examining complex cystic breast lesions found malignancy rates of about 14–16% for most subtypes, rising to 41% for lesions with solid eccentric or irregular components (classified as type IV in that study’s framework).13PubMed. Complex cystic lesions of the breast on ultrasonography: feature analysis and BI-RADS assessment If your doctor flags a breast cyst as “complex” and recommends a biopsy, those numbers explain why.
Skin cysts — particularly epidermoid cysts, those firm lumps under the skin that many people develop — are overwhelmingly benign. Malignant transformation into squamous cell carcinoma is rare, with reported incidence rates ranging widely from about 0.03% in large general-population surveys to as high as 9% in studies specifically focused on suspicious lesions.14PubMed Central. A Rare Transformation of Epidermoid Cyst into Squamous Cell Carcinoma: A Case Report with Literature Review The wide range reflects who was being studied: when you look at all epidermoid cysts in the general population, the transformation rate is vanishingly small. When you look only at cysts that already looked suspicious, the rate is predictably higher. For the average person with a typical epidermoid cyst that is not growing rapidly, not painful, and not fixed to deeper tissues, the cancer risk is extremely low.
Thyroid nodules often have cystic components, and here again the proportion of solid versus cystic tissue matters for risk. Purely cystic thyroid nodules are almost never cancerous. Partially cystic nodules sit in an intermediate range. One study examining how ultrasound features predict malignancy found that among partially cystic thyroid nodules, microcalcifications were the only imaging feature independently predictive of cancer, while solid hypoechoic nodules with any suspicious features carried a higher malignancy risk.15PubMed. Thyroid Imaging Reporting and Data System Risk Stratification of Thyroid Nodules: Categorization Based on Solidity and Echogenicity In practical terms, the more solid a thyroid nodule is, the more attention it deserves.
How Cyst Fluid Analysis Is Improving Risk Prediction
When imaging alone cannot determine whether a cyst is dangerous, doctors sometimes sample the fluid inside it. This is especially relevant for pancreatic cysts, where the decision to operate or watch can be life-altering. Traditional markers in cyst fluid include carcinoembryonic antigen (CEA), a protein whose level can help distinguish mucinous from non-mucinous cysts, and mutations in genes like KRAS and GNAS, which are associated with mucinous neoplasms.
Newer research is pushing beyond these standard tests. A study examining microRNA markers in pancreatic cyst fluid found that three specific microRNAs performed better than the traditional markers at distinguishing high-risk cysts from low-risk ones, with extremely high accuracy.16PubMed Central. An integrated multi-omics biomarker approach using molecular profiling and microRNAs for evaluation of pancreatic cyst fluid Separately, methylated DNA markers in cyst fluid have shown promise, with a two-marker panel achieving sensitivity and specificity above 90% for distinguishing advanced neoplasia from benign cysts, significantly outperforming KRAS mutations or CEA alone.17PubMed Central. Novel Methylated DNA Markers Discriminate Advanced Neoplasia in Pancreatic Cysts: Marker Discovery, Tissue Validation, and Cyst Fluid Testing
Molecular analysis using next-generation sequencing has also improved accuracy for identifying mucinous neoplasms specifically, boosting sensitivity from about 87% with conventional methods to over 94% when genetic sequencing is added.18Scientific Reports. Molecular analysis of cyst fluids improves the diagnostic accuracy of pre-operative assessment of pancreatic cystic lesions These advances are not yet universally available, but they represent a meaningful improvement in the ability to tell dangerous cysts from harmless ones without resorting to surgery. For serous cystadenomas, which are benign and ideally should not be operated on at all, fine-needle biopsy with tissue sampling dramatically improved diagnostic accuracy compared to fluid aspiration alone.19PubMed. Improving diagnostic yield of pancreatic serous cystadenoma with cyst fluid ancillary testing, adjunct immunohistochemistry, and additional fine-needle biopsy sampling
Cystic Masses in Children
In children, lung cysts deserve particular caution. Most congenital lung cysts are benign, but the earliest manifestation of pleuropulmonary blastoma (PPB), a rare childhood cancer, is a cyst in the lung that looks identical to a benign congenital cyst on imaging. There is no way to tell them apart without examining the tissue under a microscope. Surgical removal of cystic PPB cures roughly 85–90% of children, but if the cyst is left in place, it can evolve into a high-grade sarcoma by age two to six, at which point the cure rate drops to 45–60%.20PubMed. Pulmonary cysts in early childhood and the risk of malignancy
This is one of the clearest examples where a cyst that appears completely benign on every available scan can still be cancerous, and why pediatric pulmonologists tend to recommend removal of lung cysts in young children rather than a watch-and-wait approach. Many historical cases reported as “cancer arising in a congenital lung cyst” are now understood as PPB that was initially mistaken for a benign cyst.20PubMed. Pulmonary cysts in early childhood and the risk of malignancy
When Cysts Mimic Something Else
Not everything that looks like a cyst on imaging is actually a cyst, and not every cyst that looks worrying is cancerous. In the head and neck, cystic lesions have a particularly broad range of possible diagnoses. A branchial cleft cyst, for example, is a developmental remnant that is almost always benign, but the differential diagnosis for a cystic neck mass also includes metastatic squamous cell carcinoma, lymphoma, and even tuberculosis-related lymph node disease.21Acta Cytologica. Head and Neck Cystic Lesions: A Cytology Review of Common and Uncommon Entities A cystic neck mass in a middle-aged adult, especially someone with risk factors like smoking, is treated with much more suspicion than the same finding in a teenager, where a developmental cyst is far more likely.
The overlap between infectious, inflammatory, and neoplastic causes of cystic masses is one reason doctors sometimes push for biopsy even when the most likely diagnosis is benign. The imaging appearance alone cannot always distinguish between a harmless fluid collection from an infection and a cystic cancer that has outgrown its blood supply and developed a fluid-filled center.
The Anxiety of Finding a Cyst
With modern imaging becoming routine for all sorts of complaints, incidental cysts are discovered constantly, and the psychological toll is worth acknowledging. A study of participants undergoing whole-body MRI found that about 10% experienced strong distress while waiting for potential notification of an incidental finding, and nearly 29% reported moderate to severe psychological distress after being notified.22European Radiology. Psychosocial consequences and severity of disclosed incidental findings from whole-body MRI in a general population study That anxiety is understandable, but it is also disproportionate to the actual risk for most cysts. The vast majority of incidentally discovered cysts are simple, benign, and require nothing more than a single follow-up scan to confirm stability.
If you have been told you have a cyst and are trying to gauge your own risk, the single most useful piece of information is the imaging description. Ask your doctor whether the cyst is simple or complex, whether it has any solid components, and what follow-up (if any) is recommended. A simple cyst in nearly any organ is a non-event. A complex cyst with worrisome features deserves prompt follow-up and possibly tissue sampling, but even then, not all complex cysts are cancerous. The features that push a cyst into truly worrying territory are specific, well-studied, and something your imaging report will usually describe in detail.
Does Biopsy Itself Carry Risk?
One concern that occasionally surfaces is whether sticking a needle into a potentially cancerous cyst could spread cancer cells. The theoretical basis for this worry is real: tumor cells have reduced adhesion to one another and can be dislodged by a needle into surrounding tissue or the blood stream.23PubMed Central. Risk of tumor cell seeding through biopsy and aspiration cytology One study of breast cancer patients found evidence of needle tract seeding in about 32% of cases examined, though the rate was much lower when surgery followed more than 28 days after biopsy, and the displaced cells appeared to diminish over time.24PubMed Central. Reducing the Risk of Needle Tract Seeding or Tumor Cell Dissemination during Needle Biopsy Procedures
In practice, clinically significant needle tract seeding — meaning seeding that actually leads to a new tumor growing along the needle path — is rare for most cancers. The benefits of getting a tissue diagnosis almost always outweigh the theoretical risk of seeding. For certain cystic lesions, however, aspiration is specifically discouraged. Some biliary mucinous cystic neoplasms, for example, should not be aspirated before surgery because the distinction between an invasive and non-invasive form can only be made by examining the full specimen under a microscope.25PubMed Central. Invasive biliary mucinous cystic neoplasm: a review Your doctor will weigh these considerations for your specific situation; needle biopsy remains one of the safest and most reliable tools in cancer diagnosis overall, but it is not universally applied to every cystic lesion.